Drugs / Adipose-derived stromal vascular fraction cells
Adipose-derived stromal vascular fraction cells
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT05699161 | Oct 2021 → Oct 2022 | Parkinson disease | Samuel Vilchez, PhD | Completed | No outcome recorded |
| Phase 1/2 | NCT05154591 | Jan 2018 → Feb 2021 | chronic renal failure syndrome | Samuel Vilchez, PhD | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07553468 | Dec 2024 → Feb 2026 | diabetic polyneuropathy | Michael H Carstens | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adipose-derived Stromal Vascular Fraction Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07553468 ↗ |
| Known as | hSVF | “The GID SVF-1 and GID SVF-2 are closed-system, disposable, scalable cellular isolation devices designed for isolating the human adipose-derived stromal vascular fraction (hSVF)...” PMID 28177263 ↗ Mar 2017 |
| Known as | SVF | “The stromal vascular fraction (SVF), in particular, is an eclectic composite of cells with progenitor activity that includes preadipocytes, mesenchymal stem cells, pericytes,...” PMID 26546112 ↗ Oct 20151“with autologous adipose tissue-derived stromal vascular fraction (SVF) cells by subdermal plane injection into the submuscular aponeurotic fascia of the face.” NCT05699161 ↗ |
| Known as | SVF cells | “with autologous adipose tissue-derived stromal vascular fraction (SVF) cells by subdermal plane injection into the submuscular aponeurotic fascia of the face.” NCT05699161 ↗ |
| Modality | Cell therapy | “Overall, regenerative cell therapy based on SVF is at an early investigative stage but its potential for clinical application is enormous.” PMID 26565755 ↗ Oct 2015 |
| Route | Other | “Intra-arterial injection of SVF cells into the kidneys.” NCT05154591 ↗ |